Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
In This Issue
Nature Chemical Biology 2, v (1 May 2006) | doi:10.1038/nchembio0506-v
In This Issue
Abstract
Cover story Angiogenesis, the process of blood vessel growth, is hyperactivated in certain cancers. Thus, anti-angiogenic compounds, which may regulate tumor growth by restricting blood supply to malignant tissues, show great promise for cancer chemotherapy.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
